In this episode of Movement Health Matters, we talk with Silvia Blemker, PhD, the Chief Scientific Officer and Co-Founder of Springbok Analytics.
Silvia is well known in the field of muscle biomechanics and physiology for developing novel computational and experimental approaches to study muscle, with applications ranging from muscle disease to athletic performance. She has held a lifelong curiosity around the human body, muscle and movement, making her a great person to join Aaron for a discussion related to all things movement.
Silvia shares her thoughts on muscle analysis and its current limitations, the importance of defining movement health on an individual level, and how Springbok’s 3D muscle analysis technology has the potential to revolutionize how we understand muscle. Silvia led the initial scientific research that laid the foundation for the Springbok technology and continues to lead research and development at Springbok. The company works with professional athletes and organizations across the NFL, MLB, NBA and NHL, and is working with leading organizations in healthcare and life sciences to expand and evolve how the world views muscle.
What you'll learn in this episode:
Why muscle mass is good for the cardiovascular system, the entire body and the brain
The types of muscle analysis that Springbok focuses on: muscle volume, asymmetries and muscle quality
How Springbok is working with the NFL, NBA and athletes and professional sports organizations to better assess and understand injury, training and return-to-play protocols
The importance of looking at muscles individually
Why there is still so much we need to study and learn about the MSK system
The need for a normative database of individual muscle analysis across the general population
How Springbok is working to commercialize its technology across several markets, including sports, life sciences and longevity